Cargando…

A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1

Rhizomelic chondrodysplasia punctata type 1 (RCDP1) is a peroxisome biogenesis disorder caused by defects in PEX7 leading to impairment in plasmalogen (Pls) biosynthesis and phytanic acid (PA) oxidation. Pls deficiency is the main pathogenic factor that determines the severity of RCDP. Severe (class...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallatah, Wedad, Cui, Wei, Di Pietro, Erminia, Carter, Grace T., Pounder, Brittany, Dorninger, Fabian, Pifl, Christian, Moser, Ann B., Berger, Johannes, Braverman, Nancy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310236/
https://www.ncbi.nlm.nih.gov/pubmed/35898397
http://dx.doi.org/10.3389/fcell.2022.886316
_version_ 1784753345892712448
author Fallatah, Wedad
Cui, Wei
Di Pietro, Erminia
Carter, Grace T.
Pounder, Brittany
Dorninger, Fabian
Pifl, Christian
Moser, Ann B.
Berger, Johannes
Braverman, Nancy E.
author_facet Fallatah, Wedad
Cui, Wei
Di Pietro, Erminia
Carter, Grace T.
Pounder, Brittany
Dorninger, Fabian
Pifl, Christian
Moser, Ann B.
Berger, Johannes
Braverman, Nancy E.
author_sort Fallatah, Wedad
collection PubMed
description Rhizomelic chondrodysplasia punctata type 1 (RCDP1) is a peroxisome biogenesis disorder caused by defects in PEX7 leading to impairment in plasmalogen (Pls) biosynthesis and phytanic acid (PA) oxidation. Pls deficiency is the main pathogenic factor that determines the severity of RCDP. Severe (classic) RCDP patients have negligible Pls levels, congenital cataracts, skeletal dysplasia, growth and neurodevelopmental deficits, and cerebral hypomyelination and cerebellar atrophy on brain MRI. Individuals with milder or nonclassic RCDP have higher Pls levels, better growth and cognitive outcomes. To better understand the pathophysiology of RCDP disorders, we generated an allelic series of Pex7 mice either homozygous for the hypomorphic allele, compound heterozygous for the hypomorphic and null alleles or homozygous for the null allele. Pex7 transcript and protein were almost undetectable in the hypomorphic model, and negligible in the compound heterozygous and null mice. Pex7 deficient mice showed a graded reduction in Pls and increases in C26:0-LPC and PA in plasma and brain according to genotype. Neuropathological evaluation showed significant loss of cerebellar Purkinje cells over time and a decrease in brain myelin basic protein (MBP) content in Pex7 deficient models, with more severe effects correlating with Pex7 genotype. All Pex7 deficient mice exhibited a hyperactive behavior in the open field environment. Brain neurotransmitters analysis of Pex7 deficient mice showed a significant reduction in levels of dopamine, norepinephrine, serotonin and GABA. Also, a significant correlation was found between brain neurotransmitter levels, the hyperactivity phenotype, Pls level and the severity of Pex7 genotype. In conclusion, our study showed evidence of a genotype-phenotype correlation between the severity of Pex7 deficiency and several clinical and neurobiochemical phenotypes in RCDP1 mouse models. We propose that PA accumulation may underlie the cerebellar atrophy seen in older RCDP1 patients, as even relatively low tissue levels were strongly associated with Purkinje cells loss over time in the murine models. Also, our data demonstrate the interrelation between Pls, brain neurotransmitter deficiencies and the neurobehavioral phenotype, which could be further used as a valuable clinical endpoint for therapeutic interventions. Finally, these models show that incremental increases in Pex7 levels result in dramatic improvements in phenotype.
format Online
Article
Text
id pubmed-9310236
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93102362022-07-26 A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1 Fallatah, Wedad Cui, Wei Di Pietro, Erminia Carter, Grace T. Pounder, Brittany Dorninger, Fabian Pifl, Christian Moser, Ann B. Berger, Johannes Braverman, Nancy E. Front Cell Dev Biol Cell and Developmental Biology Rhizomelic chondrodysplasia punctata type 1 (RCDP1) is a peroxisome biogenesis disorder caused by defects in PEX7 leading to impairment in plasmalogen (Pls) biosynthesis and phytanic acid (PA) oxidation. Pls deficiency is the main pathogenic factor that determines the severity of RCDP. Severe (classic) RCDP patients have negligible Pls levels, congenital cataracts, skeletal dysplasia, growth and neurodevelopmental deficits, and cerebral hypomyelination and cerebellar atrophy on brain MRI. Individuals with milder or nonclassic RCDP have higher Pls levels, better growth and cognitive outcomes. To better understand the pathophysiology of RCDP disorders, we generated an allelic series of Pex7 mice either homozygous for the hypomorphic allele, compound heterozygous for the hypomorphic and null alleles or homozygous for the null allele. Pex7 transcript and protein were almost undetectable in the hypomorphic model, and negligible in the compound heterozygous and null mice. Pex7 deficient mice showed a graded reduction in Pls and increases in C26:0-LPC and PA in plasma and brain according to genotype. Neuropathological evaluation showed significant loss of cerebellar Purkinje cells over time and a decrease in brain myelin basic protein (MBP) content in Pex7 deficient models, with more severe effects correlating with Pex7 genotype. All Pex7 deficient mice exhibited a hyperactive behavior in the open field environment. Brain neurotransmitters analysis of Pex7 deficient mice showed a significant reduction in levels of dopamine, norepinephrine, serotonin and GABA. Also, a significant correlation was found between brain neurotransmitter levels, the hyperactivity phenotype, Pls level and the severity of Pex7 genotype. In conclusion, our study showed evidence of a genotype-phenotype correlation between the severity of Pex7 deficiency and several clinical and neurobiochemical phenotypes in RCDP1 mouse models. We propose that PA accumulation may underlie the cerebellar atrophy seen in older RCDP1 patients, as even relatively low tissue levels were strongly associated with Purkinje cells loss over time in the murine models. Also, our data demonstrate the interrelation between Pls, brain neurotransmitter deficiencies and the neurobehavioral phenotype, which could be further used as a valuable clinical endpoint for therapeutic interventions. Finally, these models show that incremental increases in Pex7 levels result in dramatic improvements in phenotype. Frontiers Media S.A. 2022-07-11 /pmc/articles/PMC9310236/ /pubmed/35898397 http://dx.doi.org/10.3389/fcell.2022.886316 Text en Copyright © 2022 Fallatah, Cui, Di Pietro, Carter, Pounder, Dorninger, Pifl, Moser, Berger and Braverman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Fallatah, Wedad
Cui, Wei
Di Pietro, Erminia
Carter, Grace T.
Pounder, Brittany
Dorninger, Fabian
Pifl, Christian
Moser, Ann B.
Berger, Johannes
Braverman, Nancy E.
A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title_full A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title_fullStr A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title_full_unstemmed A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title_short A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity—Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1
title_sort pex7 deficient mouse series correlates biochemical and neurobehavioral markers to genotype severity—implications for the disease spectrum of rhizomelic chondrodysplasia punctata type 1
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310236/
https://www.ncbi.nlm.nih.gov/pubmed/35898397
http://dx.doi.org/10.3389/fcell.2022.886316
work_keys_str_mv AT fallatahwedad apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT cuiwei apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT dipietroerminia apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT cartergracet apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT pounderbrittany apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT dorningerfabian apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT piflchristian apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT moserannb apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT bergerjohannes apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT bravermannancye apex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT fallatahwedad pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT cuiwei pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT dipietroerminia pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT cartergracet pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT pounderbrittany pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT dorningerfabian pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT piflchristian pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT moserannb pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT bergerjohannes pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1
AT bravermannancye pex7deficientmouseseriescorrelatesbiochemicalandneurobehavioralmarkerstogenotypeseverityimplicationsforthediseasespectrumofrhizomelicchondrodysplasiapunctatatype1